Trials / Completed
CompletedNCT01766440
PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
Pharmacokinetics and Pharmacodynamics of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 14 Days Under Conditions of Maximal Use in Pediatric Subjects (2 to 12 Years of Age) With Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if the calcitriol absorption in pediatric subjects is comparable to that in adults and adolescents, with no significant impact on calcium/phosphorus metabolism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcitriol 3 mcg/g ointment | Topical ointment; twice daily application |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2013-01-11
- Last updated
- 2021-02-18
- Results posted
- 2017-03-31
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01766440. Inclusion in this directory is not an endorsement.